scispace - formally typeset
A

Aram Prokop

Researcher at Boston Children's Hospital

Publications -  116
Citations -  3370

Aram Prokop is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Apoptosis & Leukemia. The author has an hindex of 31, co-authored 105 publications receiving 2963 citations. Previous affiliations of Aram Prokop include East China University of Science and Technology & University of Cologne.

Papers
More filters
Journal ArticleDOI

Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts

TL;DR: It is shown that resveratrol, as well as the hydroxylated analog piceatannol, are potent inducers of apoptotic cell death in BJAB Burkitt-like lymphoma cells with an ED50 concentration of 25 μM.
Journal ArticleDOI

A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.

TL;DR: Mechanistic experiments indicated that the inhibition of thioredoxin reductase (based on the covalent binding of a gold triethylphosphine fragment) might be involved in the pharmacodynamic behavior of this novel gold species.
Journal ArticleDOI

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.

TL;DR: It is concluded that in ALL relapse a severe disturbance of apoptotic pathways occurs, both at the level of Bax expression and caspase-3 activation.